EPISODE · Sep 15, 2023 · 14 MIN
The Future of MGD Treatment
from Let’s Talk Ophthalmology: an Evolve Medical Education Podcast · host Evolve Medical Education, LLC
John D. Sheppard, MD, MMSc, FACS, speaks about the future of pharmacological therapy for dry eye disease associated with meibomian gland dysfunction. This program was recorded prior to the approval of perfluorohexyloctane ophthalmic solution (formerly known as NOV03). This activity is supported by an unrestricted educational grant from Bausch + Lomb. Click here to view Dr. Sheppard's webinar event, which includes images from the talk. Want to register with Evolve Medical Education? Click here.
What this episode covers
John D. Sheppard, MD, MMSc, FACS, speaks about the future of pharmacological therapy for dry eye disease associated with meibomian gland dysfunction. This program was recorded prior to the approval of perfluorohexyloctane ophthalmic solution (formerly known as NOV03). This activity is supported by an unrestricted educational grant from Bausch + Lomb. Click here to view Dr. Sheppard's webinar event, which includes images from the talk. Want to register with Evolve Medical Education? Click here.
NOW PLAYING
The Future of MGD Treatment
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m